AIDS since 1984: No evidence for a new, viral epidemic - Not even in Africa

Italian Journal of Anatomy and Embryology

Volumn 116, Issue 2, 2011, Pages 73-92

  Duesberg, Peter H ^a   Mandrioli, Daniele ^a   McCormack, Amanda ^a   Nicholson, Joshua M ^b   Rasnick, David ^c   Fiala, Christian ^d   Koehnlein, Claus ^e   Bauer, Henry H ^b   Ruggiero, Marco ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c Gynmed Ambulatorium ^*

^d Gynmed Ambulatorium   (Austria)

^e University of Firenze   (Germany)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AIDS drugs; Anti HIV agents; Drug toxicity; HIV; Population growth

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; DEVELOPING COUNTRY; EPIDEMIC; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MORTALITY; PATHOGENICITY; PREVALENCE; REVIEW; STATISTICS; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; CAUSALITY; DEVELOPING COUNTRIES; EPIDEMICS; EVIDENCE-BASED MEDICINE; FEMALE; HIV-1; HUMANS; MALE; PREVALENCE;

EID: 82655181529     PISSN: 11226714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Aboulker J.P., Swart A.M. (1993) Preliminary analysis of the Concord trial. Lancet 341: 889-890.
2. Anderson R.M., May R.M., McLean A.R. (1988) Possible demographic consequences of AIDS in developing countries. Nature 332: 228-234. (Pubitemid 18076652)
3. Barrett B., Tardieu M., Rustin P., Lacroix C, Chabrol B., Desguerre I., Dollfus C, Mayaux M.J., Blanche S. (2003) Persistent mitochondrial dysfunction in HIV-1-ex-posed but uninfected infants: clinical screening in a large prospective cohort. Aids 17: 1769-1785. (Pubitemid 37000095)
4. Bauer H.H. (2007) The origin, persistence and failings of the HIV/AIDS theory. McFarland & Company, Inc., Publishers. Jefferson, North Carolina, and London.
5. Baumann E., Bethell T., Bialy H., Duesberg P., Faber C, Geshekter C, Johnson P., Maver R., Schoch R., Stewart G., Strohman R., Thomas Jr. C. (1995) for the Group for the Scientific Reappraisal o. the HIV/AIDS Hypothesis. AIDS Proposal. Sci-ence 267: 945-946.
6. Blattner W., Gallo R.C., Temin H.M. (1988) HIV causes AIDS. Science 241: 515-516.
7. Brogly S.B., Ylitalo N., Mofenson L.M., Oleske J., Van Dyke R., Crain M.J., Abzug M.J., Brady M., Jean-Philippe P., Hughes M.D., Seage G.R. 3rd. (2007) In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. Aids 21: 929-938. (Pubitemid 46684324)
8. California State. (2011) Chemicals known to the State to cause cancer or reproductive toxicity. Online at: http://www.oehha.ca.gov/prop65/prop65-list/ Newlist.html. Accessed February 4th, 2011.
9. Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among ado-lescents and adults. Morb. Mort. Wkly Rep. 41 (RR17): 1-19.
10. Centers for Disease Control and Prevention (2009) HIV/AIDS Surveillance Report, 2007. 19. Online at: http://www.cdc.gov/hiv/surveillance/resources/ reports/2007report/pdf/2007SurveillanceReport.pdf. Accessed March 29th, 2011.
11. Centers for Disease Control and Prevention (2010) HIV Surveillance Report, 2008. 20. Online at: http://www.cdc.gov/hiv/surveillance/resources/ reports/2008report/ pdf/2008SurveillanceReport.pdf. Accessed March 29th, 2011.
12. Centers for Disease Control and Prevention (2011) HIV/AIDS Statistics and Surveillance, 1985-2008.
13. Chigwedere P., Seage G.R. 3rd, Gruskin S., Lee T.H.E, Essex M. (2008) Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa. J. Acquir. Immune Defic. Syndr. 49: 410-415.
14. Chin J. (2007) The AIDS pandemic: The collision of epidemiology with political correctness: Radcliffe Publishing.
15. Clark S.J., Saag M.S., Decker W.D., Campbell-Hill S., Robertson J.L., Veldkamp P.J., Kap-pes J.C., Hahn B.H., Shaw G.M. (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324: 954-960.
16. Cohen D., Carter P. (2010) WHO and the pandemic flu " conspiracies". BMJ 340: c29l2.
17. Crick F.H., Watson J.D. (1956) Structure of small viruses. Nature 177: 473-475.
18. Curran J.W., Morgan M.W., Hardy S.A.M., Jaffe H.W., Darrow W.W., Dowdle W.R. (1985) The epidemiology of AIDS: current status and future prospects. Science 229: 1352-1357. (Pubitemid 16222373)
19. Daar E.S., Moudgil T., Meyer R.D., Ho D.D. (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324: 961-964.
20. DART Trial Team (2010) Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375: 123-131.
21. Department of Health South Africa (2007) Report National HIV and Syphilis Prevalence Survey South Africa 2006. Online at: http://www.doh.gov.za/docs/ reports/2007/hiv/index.html. Accessed May 18th, 2011.
22. Duesberg P.H. (1988) HIV is not the cause of AIDS. Science 241: 514-516.
23. Duesberg RH. (1989) Human immunodeficiency virus and acquired immunodeficien-cy syndrome: Correlation but not causation. Proc. Natl. Acad. Sci. USA 86: 755-764.
24. Duesberg P.H. (1991) AIDS epidemiology: inconsistencies with human immunodefi-ciency virus and with infectious disease. Proc. Natl. Acad. Sci. USA 88: 1575-1579. (Pubitemid 21916268)
25. Duesberg P.H. (1992) AIDS acquired by drug consumption and other noncontagious risk factors. Pharmacol. Ther. 55: 201-277. (Pubitemid 23031373)
26. Duesberg P.H. (1993) The HIV gap in national AIDS statistics. Biotechnology 11: 955-956. (Pubitemid 23218985)
27. Duesberg P. (1994) Infectious AIDS - Stretching the germ theory beyond its limits. Int. Arch. Allergy Immunol. 103: 118-127. (Pubitemid 24038197)
28. Duesberg P.H. (1996) Inventing the AIDS Virus. Washington DC: Regnery Publishing Inc.
29. Duesberg P., Koehnlein C, Rasnick D. (2003) The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition. J. Biosci. 28: 383-412. (Pubitemid 36750046)
30. El-Sadr W.M., Lundgren J.D., Neaton J.D., Gordin F., Abrams D., Arduino R.C., Babik-er A., Burman W., Clumeck N., Cohen C.J., Cohn D., Cooper D., Darbyshire J., Emery S., Fatkenheuer G., Gazzard B., Grund B., Hoy J., Klingman K., Losso M., Markowitz N., Neuhaus J., Phillips A., Rappoport C. (2006) CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med. 355: 2283-2296. (Pubitemid 44837777)
31. Encyclopædia Britannica. (2010) "germ theory". Encyclopædia Britannica Online, http://www.britannica.com/EBchecked/topic/ 230610/germ-theory. Accessed February 4th, 2011.
32. Escobar PA., Olivero O.A., Wade N.A., Abrams E.J., Nesel C.J., Ness R.B., Day R.D., Day B.W., Meng Q., O'Neill J.P, Walker D.M., Poirier M.C., Walker V.E., Bigbee W.L. (2007) Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC. Environ. Mol. Mutagen. 48: 330-343. (Pubitemid 46536100)
33. Fenner F., McAuslan B.R., Mims C.A., Sambrook J., White D.O. (1974) The Biology of Animal Viruses. Academic Press Inc., New York.
34. Fiala C. (2003) AIDS in Africa: a call for sense, not hysteria. BMJ, Published August 19. Online at: http://www.bmj.com/letters, to be reached from the "search" field by article title. Accessed June 9, 2011.
35. Rapid Response to Sidley P. (2003) Free retroviral drugs could save up to 1.7 million South Africans. BMJ, 327: 184
36. Fields B. (2001) Field's Virology. Lippincott Williams & Wilkins, Philadelphia.
37. Fischl M.A., Richman D.D., Grieco M.H., Gottlieb M.S., Volberding PA., Laskin O.L., Leedom J.M., Groopman J.E., Mildvan D., Schooley R.T., Jackson G.G., Durack D.T., Phil D., King D., the AZT Collaborative Working Group. (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl. J. Med. 317: 185-191. (Pubitemid 17114872)
38. Fischl M.A., Richman D.D., Causey D.M., Grieco M.H., Bryson Y., Mildvan D., Laskin O.L., Groopman J.E., Volberding P.A., Schooley R.T., Jackson G.G., Durack D.T., Andrews J.C., Nusinoff-Lehrman S., Barry D.W., the AZT Collaborative Working Group. (1989) Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 262: 2405-2410. (Pubitemid 19261812)
39. Freeman B.A. (1979) Burrows Textbook of Microbiology. W. B. Saunders Co., Philadelphia.
40. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kaplan M., Haynes B.F., Palk-er T.J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P.D. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503. (Pubitemid 14134741)
41. Gisselquist D., Rothenberg R., Potterat J., Drucker E. (2002) HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int. J. STD AIDS 13: 657-666.
42. Goodgame R.W. (1990) AIDS in Uganda-clinical and social features. N. Engl. J. Med. 323: 383-389. (Pubitemid 20243905)
43. Henry W.K., Tebas P., Lane H.C. (2006) Explaining, predicting, and treating HIV-asso-ciated CD4 cell loss: after 25 years still a puzzle. JAMA 296: 1523-1525. (Pubitemid 44465518)
44. Heresi G.P., Caceres E., Atkins J.T., Rueben J., Doyle M. (1997) Pneumocystis carinii pneumonia in infants who were exposed to human immunodeficiency virus but were not infected: an exception to the AIDS Surveillance case definition. Clin. Infect. Dis. 25: 739-740. (Pubitemid 27392624)
45. Horwitz J.P., Chua J., Noel M. Nucleosides. V. (1964) The monomesylates of 1-(2'-deoxy-beta-D-lyxofuranosyl)thymidine. J. Org. Chem. 29: 2076.
46. Institute of Historical Research (1990) ii Epidemics and mortality in the pre-industrial city:Florence and London compared. In: Centre for Metropolitan History, Annual Report 1989-1990. University of London, School of Advanced Study. London. Pp. 11-17.
47. Institute of Medicine, National Academy of Sciences (1986) Confronting AIDS. Washington, DC: National Academy Press.
48. Istituto Superiore di Sanità (2007) AIDS in Italy. Online at http://www.salute.gov.it/ resources/static/primopiano/503/DATI-AIDS-ISS.pdf. Accessed February 4th, 2011.
49. Kolata G. (1987) Imminent marketing of AZT raises problems;Marrow suppression hampers AZT use in AIDS victims. Science 235: 1462-1463.
50. Lohse N, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Nielsen L, Sorensen HT, Obel N. (2011) Comorbidity acquired before HIV diagnosis and mortality in persons Infected and uninfected with HIV: A Danish population-based ochort study. J Acquir Immune Defic Syndr; 57:334-339.
51. Merson M.H. (1993) Slowing the spread of HIV:Agenda for the 1990s. Science 260: 1266-1268.
52. Mims C, White D.O. (1984) Viral Pathogenesis and Immunology. Blackwell Scientific Publications, Oxford.
53. Ministero della Salute (2011) HIV e AIDS. Dati Epidemiologici. Online at: http:// www.salute.gov.it/hiv/paginaInternaHiv.jspuid=198&menu= strumentieservizi. Accessed February 4th, 2011.
54. Monini P., Sgadari C, Toschi E., Barillari G., Ensoli B. (2004) Antitumour effects of antiretroviral therapy. Nat. Rev. Cancer 4: 861-875. (Pubitemid 39472953)
55. Mulder D.W., Nunn A.J., Wagner H.U., Kamali A., Kengeya-Kayondo J.F. (1994a) HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort. AIDS 8: 87-92. (Pubitemid 24094093)
56. Mulder D.W., Nunn A.J., Kamali A., Nakiyingi J., Wagner H.U., Kengeya-Kayondo J.F. (1994b) Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 343: 1021-1023. (Pubitemid 24122614)
57. Nunes E.P., Grinsztejn B., Schechter M. (2011) The DART Trial: 'The Doctor's Dilemma' revisited. J. Antimicrob. Chemother. 66:964-967.
58. Okulicz J.F., Marconi V.C., Landrum M.L., Wegner S., Weintrob A., Ganesan A., Hale B., Crum-Cianflone N., Delmar J., Barthel V., Quinnan G., Agan B.K., Dolan M.J.; and the Infectious Disease Clinical Research Program (IDCRP) HIV Working Group. (2009) Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J. Infect. Dis. 200: 1714-1723.
59. Panel de expertos de Gesida y Plan Nacional sobre el Sida (2011) Documento de consenso de GESIDA/ Plan Nacional sobre el Sida respecto al tratamiento antir-retroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2011) Enferm. Infecc. Microbiol. Clin. 29: 209.el-209.el03.
60. Payne BA, Wilson IJ, Hateley CA, Horvath R, Santibanez-Koref M, Samuels DC, Price DA, Chinnery PF. (2011) Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat. Genet. 43: 806-810.
61. Poirier M.C., Divi R.L., Al-Harthi L., Olivero O.A., Nguyen V, Walker B., Landay A.L., Walker V.E., Charurat M., Blattner W.A. (2003) Long-term mitochondrial tox-icity in HIV-uninfected infants born to HIV-infected mothers. J. Acquir. Immune Defic. Syndr. 33: 175-183. (Pubitemid 36793152)
62. Quinn T.C., Mann J.M., Curran J.W., Piot P. (1986) AIDS in Africa: an epidemiologic paradigm. Science 234: 955-963. (Pubitemid 17193017)
63. Reisler R.B., Han C, Burman W.J., Tedaldi E.M., Neaton J.D. (2003) Grade 4 events are as important as AIDS events in the era of HAART. J. Acquir. Immune Defic. Syndr. 34: 379-386. (Pubitemid 37444465)
64. Renzullo P.O., Sateren W.B., Garner R.P., Milazzo M.J., Birx D.L., McNeil J.G. (2001) HIV-1 seroconversion in United States Army active duty personnel, 1985-1999. AIDS 15: 1569-1574. (Pubitemid 32744605)
65. Richman D.D., Fischl M.A., Grieco M.H., Gottlieb M.S., Volberding PA., Laskin O.L., Leedom J.M., Groopman J.E., Mildvan D., Hirsch M.S., Jackson G.G., Durack D.T., Nusinoff-Lehrman S., the AZT Collaborative Working Group. (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317: 192-197. (Pubitemid 17103099)
66. Rodriguez B., Sethi A.K., Cheruvu V.K., Mackay W., Bosch R.J., Kitahata M., Boswell S.L., Mathews W.C., Bangsberg D.R., Martin J., Whalen C.C., Sieg S., Yadavalli S., Deeks S.G., Lederman M.M. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296: 1498-1506. (Pubitemid 44465514)
67. Ruggiero M., Galletti Prayer M., Pacini S., Punzi T., Morucci G., Gulisano M. (2009) On the risk of contracting AIDS at the dissection table. Ital. J. Anat. Embryol. 114: 97-108.
68. Seligmann M., Warrell D.A., Aboulker J-P, Carbon C, Darbyshire J.H., Dormont J., Eschwege E., Girling D.J., James D.R., Levy J-P., Peto P.T.A., Schwarz D., Stone A.B., Weller I.V.D., Withnall R., Gelmon K., Lafon E., Swart A.M., Aber V.R., Babiker A.G., Lhoro S., Nunn A.J., Vray M. (1994) Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343: 871-881. (Pubitemid 24113630)
69. Siegfried N., Uthman O.A., Rutherford G.W. (2011) Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst. Rev.: CD008272.
70. Statistics South Africa (2000) Statistics in brief, 2000. Statistics South Africa. Online at: http://www.statssa.gov.za/publications/statsdownload. asp?PPN=StatsInBrief&SCH=2359. Accessed May 18th, 2011.
71. Statistics South Africa (2007) Mid-year population estimates, 2007. Statistics South Africa. Online at: www.statssa.gov.za/publications/ statsdownload. asp?PPN=P0302&SCH=3952. Accessed May 18th, 2011.
72. Statistics South Africa (2008) Mortality and causes of death in South Africa: Findings from death notification, 2006. Statistics South Africa. Online at
73. Stewart G.T., Mhlongo S., de Harven E., Fiala C, Koehnlein C, Herxheimer A., Dues-berg PH., Rasnick D., Giraldo R., Kothari M., Bialy H., Geshekter C. (2000) The Durban Declaration is not accepted by all. Nature 407: 286.
74. Sturt A.S., Dokubo E.K., Sint T.T. (2010) Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst. Rev: CD008440
75. The Durban Declaration (2000) The Durban declaration. Nature 406: 15-16.
76. US Census Bureau, International Data Base (2008) Population South Africa. U.S. Department of Commerce.
77. US Department of Health and Human Services (2009) AIDSinfo. Online at http:// www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int-id=4 and http:// www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int-id=116. Accessed February 4th, 2011.
78. Weiss R., Jaffe H. (1990) Duesberg, HIV and AIDS. Nature 345: 659-660. (Pubitemid 20186539)
79. Woodman Z., Williamson C. (2009) HIV molecular epidemiology: transmission and adaptation to human populations. Curr. Opin. HIV AIDS 4: 247-252.
80. World Bank (2008) Population of Sub-Saharan Africa (developing only). Online at: http://databank.worldbank.org/ddp/editReport?REQUEST-SOURCE= search&C NO=2&country=SSA&series=&period=. Accessed May 18th, 2011.
81. World Health Organization, UNAIDS, UNICEF (2008a) Epidemiological fact sheet on HIV and AIDS; Core data on epidemiology and response Uganda. Geneva. 1-18.
82. World Health Organization, UNAIDS, UNICEF (2008b) Epidemiological fact sheet on HIV and AIDS; Core data on epidemiology and response, South Africa. Geneva. 1-19.